All News
FDA ApprovalApril 11, 2026
FDA Approval: New Guidance Documents
Xarelto is a medication used to prevent and treat blood clotting disorders.
FDA Approval: New Guidance Documents
The US Food and Drug Administration (FDA) has published new guidance documents.
The medication name is Rivaroksaban (Xarelto).
Xarelto is used to prevent and treat blood clotting disorders such as deep vein thrombosis (DVT) and pulmonary embolism (PE).
Xarelto is an anticoagulant medication that works by inhibiting Factor Xa.
The side effects of Xarelto include increased risk of bleeding, headache, nausea, and diarrhea.
In Turkey, Xarelto is an approved medication by the Ministry of Health.